Microdosing GLP-1 for autoimmune conditions is an area of active investigation, and conditions like Hashimoto thyroiditis and endometriosis have both been explored in the context of GLP-1 therapy
This is the very first question people ask about Lifewaves products
J Cell Mol Med 13(8A):14991512 Cong W, Zhao T, Zhu Z, Huang B, Ma W, Wang Y et al (2014) Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase
Both Novo Nordisk and Lilly have responded to demand for their GLP-1 drugs outpacing supply by building and/or buying new facilities worldwidesuch as Novo Nordisks planned $4.1 billion second fill/finish site in Clayton, NC
10.1016/j.xgen.2025.100768 Cell Genom
Whats more, the slow-and-steady group still lost about as much weight as their peers